NPO Petrovax

Industry · 14 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Enrolling By Invitation	Efficacy and Safety of Enzyme Replacement Therapy in Patients With Fabry Disease Fabry Disease	—	2025-03-24
Recruiting	Assessment of Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE in Comparison With the Reference Dr Infections, Meningococcal	Phase 3	2025-02-12
Completed	Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prost Lower Urinary Tract Symptoms, Prostatic Hyperplasia	N/A	2023-03-20
Completed	A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus Influenza, Influenza A, Influenza, Human	Phase 3	2022-09-21
Completed	A Study of the Feasibility of Using the Dietary Supplement "ARTNEO" in Patients With Osteoathritis Osteoarthritis, Knee, Osteoarthritis, Knee Osteoarthritis	N/A	2022-05-31
Completed	Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID Post-Acute COVID-19 Syndrome, Lung Disease With Polymyositis, Fibrosis	Phase 3	2022-04-08
Completed	A Study to Assess Efficacy of Supporting Properties and Safety of ARTNEO in Patients With Knee Osteoarthritis Osteoarthritis, Osteo Arthritis Knee, Osteoarthritis, Knee	N/A	2022-03-21
Completed	Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 Covid19	Phase 3	2020-09-11
Completed	Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by C Fibroses, Pulmonary	—	2020-07-01
Completed	Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 Infections, Coronavirus	Phase 2 / Phase 3	2020-04-28
Completed	Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19 Infections, Coronavirus	—	2020-03-31
Unknown	Study of the Efficacy and Safety of Longidaze® for the Treatment of Patients With External Genital Endometrios External Genital Endometriosis	—	2019-12-26
Completed	Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI Acute Respiratory Infection	Phase 3	2018-11-07
Completed	Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Vo Influenza	Phase 2 / Phase 3	2016-11-01